Over the past several years, the visual function of people living with multiple sclerosis (MS) has been increasingly recognized as an important marker of quality of life in MS, and as a useful indicator of the severity and activity of MS both clinically, and in MS research. Measurement of a person’s ability to see faded letters (low contrast acuity) has been found to be an excellent marker of MS visual function, and its change over time is related to MS disease activity. Optical coherence tomography (OCT), which measures the health of optic nerves and retinas in individuals with MS, is providing an explosion of data that has increased our insight into the extent, course, and pathology of multiple sclerosis.
At this year’s North American Neuro-ophthalmology Society meeting, data was presented on another technique that is being developed and refined for use in the MS population, a questionnaire about visual quality of life. The “Neuro-ophthalmic supplement to the NEI-VFQ-25” is a ten-question survey that has been designed to determine the visual quality of life in people with MS and other neurologic disorders. Data so far show that the survey is effective at distinguishing people with MS from people with no neurologic conditions, implying that the survey is sensitive to the visual problems that develop in people with MS. In addition, the survey was shown to be able to distinguish people with MS who had had optic neuritis (an MS relapse involving the optic nerve) compared to those who had never had optic neuritis. The survey score also correlated with health of the optic nerves, as determined by OCT. These findings suggest that the survey will be sensitive to visual problems that change in MS over time, either due to optic neuritis or progression.
Low-contrast acuity testing and OCT are currently available to people with MS at our MS Eye Clinic. We will consider adding the NEI-VFQ-25 with the Neuro-ophthalmic supplement, as more data is available.
Recommended for you
Swedish is a leader in innovative solutions for spinal pain
Swedish is one of only a few U.S. centers involved in trials designed to prove the safety of a new artificial disc for degenerative disc disease patients.
With Swedish’s telehealth services, multiple sclerosis patients have more options for care
Virtual visits bring advanced care to more communities and relieve the strain and cost of traveling for many patients with MS.
Essential tremor ran in this family. Swedish neuroscience experts used focused ultrasound to treat the condition, which has plagued them for decades. Learn more.
Empathy, love and compassion are essential for patients with chronic pain and those who care for them
Providence Swedish experts share some advice for building supportive relationships between patients, caregivers and loved ones.
Swedish is the first Washington State hospital to offer groundbreaking ALS treatment
Tofersen, a new drug, is the first gene therapy for a familial form of amyotrophic lateral sclerosis.
What is Guillain-Barré Syndrome?
A Swedish expert discusses the autoimmune disease and its diagnosis and treatment.
Watch video: Balance is the key to meeting life's demands in a healthy way
A Swedish behavioral health expert offers guidance for finding our way back to center when life feels overwhelming.
Swedish is a destination for innovative, world-class care
Seattle’s KING 5 TV hosted a panel of sought-after Swedish specialists for a conversation about advanced treatments at Swedish and why patients from around the world choose us for their care.
Focused ultrasounds treat tremors, restoring patients' quality of life
A Swedish patient shares his experience of the procedure's life-changing success.
Understanding aphasia
A Swedish expert explains aphasia, a disorder that affects the area of your brain that controls language and communication.
Watch videos: Learn how Swedish's MS Center Adventure Program fosters joy and community
Occupational Therapist Simon Gale, the program's leader, on New Day Northwest. Share the thrill of skydiving with a program participant.
Parkinson's Foundation designates Swedish's Movement Disorders Program as a Comprehensive Care Center
The Parkinson’s Foundation Comprehensive Care Center designation recognizes leadership in providing high-quality care for patients with Parkinson’s disease.
The FDA has approved a game-changing drug for Alzheimer's disease. What should you know?
Nancy Isenberg, M.D., medical director of Swedish’s Center for Healthy Aging, weighs in.
Providence Swedish joined a host of community partners on June 21 for a Brain Health Block Party to raise awareness about the importance of brain health.
Providence Swedish is nationally recognized for providing high-quality stroke care
The American Heart Association presents the Get With The Guidelines awards for proven dedication to best practices and life-saving care.
New hope on the horizon for brain tumor patients
Clinical research at The Ivy Center at Swedish offers advanced, personalized care for brain tumors. Learn what’s giving our experts new hope.
Stroke: Symptoms, risk and other tips from a Swedish expert
Stroke: Symptoms, risk and other tips from a Swedish expert
Swedish hosts inaugural Healthy Aging Summit
The community event brought together Swedish experts and local artists who shared best practices for aging well physically, emotionally and mentally.
Helping ALS patients preserve their highest quality of life
Swedish is home to a Certified Center of Excellence for ALS care and offers patients the highest levels of multi-disciplinary care.
Living well with Parkinson’s disease
A movement expert at Swedish shares how research, medication and teamwork is improving care for people with Parkinson’s disease.